USE OF FDA-APPROVED PSILOCYBIN

HB 336 amends New Mexico's Controlled Substances Act to exempt FDA-approved synthetic psilocybin or drugs containing it from Schedule I restrictions. If the federal FDA approves such synthetic psilocybin products, they become legally usable in New Mexico without state scheduling. The bill specifically targets synthetic versions (not natural psilocybin from mushrooms) and maintains existing exemptions for religious peyote use and hemp. This creates a pathway for medical or research use of federally approved synthetic psilocybin products once FDA clearance is obtained. The law does not affect current recreational or natural psilocybin regulations.